Sign Up Today and Learn More About Jasper Therapeutics Stock
Invest in or calculate the value of your shares in Jasper Therapeutics or other pre-IPO companies through EquityZen's platform.
Jasper Therapeutics Stock
Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic
About Jasper Therapeutics Stock
Founded
2018
Industries
Software, Artificial Intelligence, Data and Analytics
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Investors in Jasper Therapeutics
Discover investors in Jasper Therapeutics stock and explore their portfolio companies
Jasper Therapeutics Management
Leadership team at Jasper Therapeutics
Co-Founder & Vice President Operations & Program Management
Susan Prohaska
Co-Founder & Member Board of Directors
Judith Shizuru M.D.
Join now and verify your accreditation status to gain access to:
- Jasper Therapeutics current valuation
- Jasper Therapeutics stock price
- Available deals in Jasper Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Jasper Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Jasper Therapeutics through EquityZen funds. These investments are made available by existing Jasper Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Jasper Therapeutics stock?
Shareholders can sell their Jasper Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
